Navigation Links
Scientists in Singapore and Europe to collaborate
Date:10/13/2011

HEIDELBERG -- Scientists in Singapore and Europe will have new avenues for scientific interaction, following a cooperation agreement between EMBO, its intergovernmental funding body, EMBC, and the government of Singapore. The agreement will allow Singapore scientists to participate in EMBO training programmes and activities. It also means that EMBO workshops and lectures can take place in Singapore. This is the first cooperation agreement of its kind between EMBO, EMBC and Singapore.

"EMBO promotes and encourages the development of the life sciences within Europe and beyond. We welcome the opportunity to ensure the mobility of scientists between Singapore and Europe and we look forward to the scientific collaboration that this agreement will bring," said EMBO Director Maria Leptin.

Chairman of the Singapore Agency for Science, Technology and Research (A*STAR), Mr Lim Chuan Poh, said that Singapore shared the same vision. "We are confident that this agreement will spur international collaborations in world-class scientific research, which will pave the way for new biomedical discoveries and global healthcare solutions."

A*STAR represented Singapore in negotiations. The agreement brings together major players in Singapore's biomedical research scene, namely A*STAR, the National University of Singapore (NUS) and the Nanyang Technological University (NTU).

New opportunities for scientific interaction

Under the agreement, scientists can apply for EMBO Short-Term and Long-Term Fellowships to work in Singapore or Europe. Scientists from Singapore can apply to the EMBO Young Investigator Programme, which provides outstanding young scientists with financial, academic and practical support to start up their first independent research laboratories.

Singapore and EMBO will also cooperate in the organization of an EMBO Workshop in Singapore, which will help to spark cross-disciplinary collaborations. The workshop organizers from Singapore and Europe can apply for funding for an EMBO Member or Young Investigator as plenary lecturer at their event. Other conferences in Singapore can also apply for the support of an EMBO Member or Young Investigator as speaker.

The cooperation agreement will run for three years.

Singapore and EMBO: a growing relationship

The cooperation agreement builds on a growing series of exchanges between Singapore and scientists associated with EMBO. Key EMBO Members based in Singapore include NTU President Professor Bertil Andersson; A*STAR Chief Scientist, Professor Sir David Lane; Chairman of A*STAR's Biomedical Research Council, Professor Sir George Radda; and NTU Professor of Biological Sciences and Chair of EMBO Council, Daniela Rhodes. Since 2005, there have been eight EMBO-funded events in Singapore, including a 2011 Plenary Lecture. In 2009, 12 EMBO Gold Medalists presented their work and held discussions with 300 researchers based in Singapore on a range of topics in developmental, cell and molecular biology.


'/>"/>
Contact: Suzanne Beveridge
communications@embo.org
European Molecular Biology Organization
Source:Eurekalert

Related medicine news :

1. Scientists Pinpoint Area of Brain That Fears Losing Money
2. Scientists Discover How HIV Is Transmitted Between Men
3. Prevention Is Key Research Goal for Premature Babies, Scientists Say
4. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
5. Scientists find donut-shaped structure of enzyme involved in energy metabolism
6. Neuroscientists reveal new links that regulate brain electrical activity
7. Two UCSF Scientists to Receive Prestigious Dementia Research Honor
8. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
9. Scientists Spot Genetic Fingerprints of Individual Cancers
10. Scientists Unravel Mysteries of Intelligence
11. MSU scientists develop more effective method of predicting lead-poisoning risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... Bump eRaiser, recently attended the January ECRM Trade Show in Hilton Head, SC, where ... an international reputation for the quality of its beauty and wellness products. At this ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni ... line-up of events for its annual meeting “Coming Home 2017,” an activity-packed weekend ... Home 2017” will be held on Friday January 27 through Sunday, January 29, ...
(Date:1/20/2017)... ... , ... Spectrum Aquatics Launches New ADA Portable Motion Trek BP 300 Lift. Built for durability, ... on wheels, it can be wheeled out of the way and stored when not in ... "We have transformed the feedback from customers into specific enhancements and created a new product ...
(Date:1/20/2017)... ... 2017 , ... Bionic Sports Nutrition LLC, an American company devoted to developing ... successful January ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition ... provide its products to all clients at reasonable prices. At the ECRM trade show, ...
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Massachusetts , January 19, 2017 ... ) announced that the U.S. Food and Drug Administration ... of a New Drug Application (NDA) for SHP465, a ... evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder ... on or around June 20, 2017, the designated Prescription ...
(Date:1/19/2017)... Pfizer joins Astex, AstraZeneca, ... Consortium   Major research investment to ...   The Milner Therapeutics Institute today ... a partner to the Milner Therapeutics Consortium. Pfizer has ... transfer of materials between industry and academia and allocation ...
(Date:1/19/2017)... 2017 While various reports ... reducing the FDA,s regulatory strictness as a way ... drug industry, many of the leading biotech and ... and development of advanced drug treatments and therapies.  ... developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: